Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate

References

• Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracellular Vesicles. 2018;7(1):1535750.30637094
   PubMed Web of Science ®Google Scholar
• Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2(8):569–579. doi:10.1038/nri85512154376
   PubMed Web of Science ®Google Scholar
• Van Niel G, d’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213. doi:10.1038/nrm.2017.12529339798
   PubMed Web of Science ®Google Scholar
• Johnstone RM, Adam M, Hammond J, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262(19):9412–9420.3597417
   PubMed Web of Science ®Google Scholar
• Shao H, Im H, Castro CM, Breakefield X, Weissleder R, Lee H. New technologies for analysis of extracellular vesicles. Chem Rev. 2018;118(4):1917–1950. doi:10.1021/acs.chemrev.7b0053429384376
   PubMed Web of Science ®Google Scholar
• Andaloussi SE, Mäger I, Breakefield XO, Wood MJ. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12(5):347–357. doi:10.1038/nrd397823584393
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:6478. doi:10.1126/science.aau6977
   Web of Science ®Google Scholar
• Crenshaw BJ, Gu L, Sims B, Matthews QL. Exosome biogenesis and biological function in response to viral infections. Open Virol J. 2018;12:134.30416610
   PubMedGoogle Scholar
• Zhou B, Xu K, Zheng X, et al. Application of exosomes as liquid biopsy in clinical diagnosis. Signal Transduction Targeted Therapy. 2020;5(1):1–14. doi:10.1038/s41392-020-00258-932296011
   PubMed Web of Science ®Google Scholar
• Syn NL, Wang L, Chow EK-H, Lim CT, Goh B-C. Exosomes in cancer nanomedicine and immunotherapy: prospects and challenges. Trends Biotechnol. 2017;35(7):665–676. doi:10.1016/j.tibtech.2017.03.00428365132
   PubMed Web of Science ®Google Scholar
• Farooqi AA, Desai NN, Qureshi MZ, et al. Exosome biogenesis, bioactivities and functions as new delivery systems of natural compounds. Biotechnol Adv. 2018;36(1):328–334. doi:10.1016/j.biotechadv.2017.12.01029248680
   PubMed Web of Science ®Google Scholar
• Maia J, Caja S, Strano Moraes MC, Couto N, Costa-Silva B. Exosome-based cell-cell communication in the tumor microenvironment. Frontiers Cell Developmental Biology. 2018;6:18. doi:10.3389/fcell.2018.00018
   PubMed Web of Science ®Google Scholar
• Shi X, Cheng Q, Hou T, et al. Genetically engineered cell-derived nanoparticles for targeted breast cancer immunotherapy. Mol Ther. 2020;28(2):536–547. doi:10.1016/j.ymthe.2019.11.02031843452
   PubMed Web of Science ®Google Scholar
• Munoz JL, Bliss SA, Greco SJ, Ramkissoon SH, Ligon KL, Rameshwar P. Delivery of functional anti-miR-9 by mesenchymal stem cell–derived exosomes to glioblastoma multiforme cells conferred chemosensitivity. Molecular Therapy-Nucleic Acids. 2013;2:e126. doi:10.1038/mtna.2013.6024084846
   PubMed Web of Science ®Google Scholar
• Lu M, Zhao X, Xing H, et al. Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA. Int J Pharm. 2018;550(1–2):100–113. doi:10.1016/j.ijpharm.2018.08.04030138707
   PubMedGoogle Scholar
• Liao W, Du Y, Zhang C, et al. Exosomes: the next generation of endogenous nanomaterials for advanced drug delivery and therapy. Acta Biomater. 2019;86:1–14. doi:10.1016/j.actbio.2018.12.04530597259
   PubMed Web of Science ®Google Scholar
• Kamerkar S, LeBleu VS, Sugimoto H, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546(7659):498–503. doi:10.1038/nature2234128607485
   PubMed Web of Science ®Google Scholar
• Gudbergsson JM, Jønsson K, Simonsen JB, Johnsen KB. Systematic review of targeted extracellular vesicles for drug delivery–considerations on methodological and biological heterogeneity. J Control Release. 2019;306:108–120. doi:10.1016/j.jconrel.2019.06.00631175896
   PubMed Web of Science ®Google Scholar
• Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem. 2019;88:487–514. doi:10.1146/annurev-biochem-013118-11190231220978
   PubMed Web of Science ®Google Scholar
• Shah R, Patel T, Freedman JE. Circulating extracellular vesicles in human disease. N Engl J Med. 2018;379(10):958–966. doi:10.1056/NEJMra170428630184457
   PubMed Web of Science ®Google Scholar
• Wan M, Ning B, Spiegel S, Lyon CJ, Hu TY. Tumor‐derived exosomes (TDEs): how to avoid the sting in the tail. Med Res Rev. 2020;40(1):385–412. doi:10.1002/med.2162331318078
   PubMed Web of Science ®Google Scholar
• Johnsen KB, Gudbergsson JM, Skov MN, Pilgaard L, Moos T, Duroux M. A comprehensive overview of exosomes as drug delivery vehicles—endogenous nanocarriers for targeted cancer therapy. Biochimica Et Biophysica Acta (BBA)-Reviews Cancer. 2014;1846(1):75–87. doi:10.1016/j.bbcan.2014.04.005
   PubMed Web of Science ®Google Scholar
• Bunggulawa EJ, Wang W, Yin T, et al. Recent advancements in the use of exosomes as drug delivery systems. J Nanobiotechnology. 2018;16(1):1–13. doi:10.1186/s12951-018-0403-929321058
   PubMed Web of Science ®Google Scholar
• Balachandran B, Yuana Y. Extracellular vesicles-based drug delivery system for cancer treatment. Cogent Medicine. 2019;6(1):1635806. doi:10.1080/2331205X.2019.1635806
   Google Scholar
• Salunkhe S, Basak M, Chitkara D, Mittal A. Surface functionalization of exosomes for target-specific delivery and in vivo imaging & tracking: strategies and significance. J Control Release. 2020;326:599–614. doi:10.1016/j.jconrel.2020.07.04232730952
   PubMed Web of Science ®Google Scholar
• Pérez-Bermúdez P, Blesa J, Soriano JM, Marcilla A. Extracellular vesicles in food: experimental evidence of their secretion in grape fruits. Eur J Pharm Sci. 2017;98:40–50. doi:10.1016/j.ejps.2016.09.02227664331
   PubMed Web of Science ®Google Scholar
• Kusuma RJ, Manca S, Friemel T, Sukreet S, Nguyen C, Zempleni J. Human vascular endothelial cells transport foreign exosomes from cow’s milk by endocytosis. American J Physiology-Cell Physiology. 2016;310(10):C800–C807. doi:10.1152/ajpcell.00169.2015
   PubMed Web of Science ®Google Scholar
• Yang D, Zhang W, Zhang H, et al. Progress, opportunity, and perspective on exosome isolation-efforts for efficient exosome-based theranostics. Theranostics. 2020;10(8):3684. doi:10.7150/thno.4158032206116
   PubMed Web of Science ®Google Scholar
• Tian Y, Li S, Song J, et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials. 2014;35(7):2383–2390. doi:10.1016/j.biomaterials.2013.11.08324345736
   PubMed Web of Science ®Google Scholar
• Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol. 2007;7(8):610–621. doi:10.1038/nri213217627284
   PubMed Web of Science ®Google Scholar
• Pitt JM, André F, Amigorena S, et al. Dendritic cell–derived exosomes for cancer therapy. J Clin Invest. 2016;126(4):1224–1232. doi:10.1172/JCI8113727035813
   PubMed Web of Science ®Google Scholar
• Zhu L, Kalimuthu S, Gangadaran P, et al. Exosomes derived from natural killer cells exert therapeutic effect in melanoma. Theranostics. 2017;7(10):2732. doi:10.7150/thno.1875228819459
   PubMed Web of Science ®Google Scholar
• Wu C-H, Li J, Li L, et al. Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells. J Extracellular Vesicles. 2019;8(1):1588538. doi:10.1080/20013078.2019.158853830891164
   PubMed Web of Science ®Google Scholar
• Timmers L, Lim SK, Hoefer IE, et al. Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res. 2011;6(3):206–214. doi:10.1016/j.scr.2011.01.00121419744
   PubMed Web of Science ®Google Scholar
• Li L, Zhang Y, Mu J, et al. Transplantation of human mesenchymal stem cell-derived exosomes immobilized in an adhesive hydrogel for effective treatment of spinal cord injury. Nano Lett. 2020.
   Web of Science ®Google Scholar
• Mianehsaz E, Mirzaei HR, Mahjoubin-Tehran M, et al. Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis? Stem Cell Res Ther. 2019;10(1):340.31753036
   PubMed Web of Science ®Google Scholar
• Peng Y, Zhao J-L, Peng Z-Y, Xu W-F, Yu G-L. Exosomal miR-25-3p from mesenchymal stem cells alleviates myocardial infarction by targeting pro-apoptotic proteins and EZH2. Cell Death Dis. 2020;11(5):1–15.31911576
   PubMed Web of Science ®Google Scholar
• Yeo RWY, Lai RC, Zhang B, et al. Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. Adv Drug Deliv Rev. 2013;65(3):336–341. doi:10.1016/j.addr.2012.07.00122780955
   PubMed Web of Science ®Google Scholar
• Dumont J, Euwart D, Mei B, Estes S, Kshirsagar R. Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives. Crit Rev Biotechnol. 2016;36(6):1110–1122.26383226
   PubMed Web of Science ®Google Scholar
• Bellavia D, Raimondo S, Calabrese G, et al. Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth. Theranostics. 2017;7(5):1333–1345. doi:10.7150/thno.1709228435469
   PubMed Web of Science ®Google Scholar
• Zhu X, Badawi M, Pomeroy S, et al. Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells. J Extracellular Vesicles. 2017;6(1):1324730. doi:10.1080/20013078.2017.132473028717420
   PubMed Web of Science ®Google Scholar
• Ostrowski M, Carmo NB, Krumeich S, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12(1):19–30.19966785
   PubMed Web of Science ®Google Scholar
• Kim SM, Yang Y, Oh SJ, Hong Y, Seo M, Jang M. Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting. J Control Release. 2017;266:8–16. doi:10.1016/j.jconrel.2017.09.01328916446
   PubMed Web of Science ®Google Scholar
• Smyth T, Kullberg M, Malik N, Smith-Jones P, Graner MW, Anchordoquy TJ. Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Control Release. 2015;199:145–155. doi:10.1016/j.jconrel.2014.12.01325523519
   PubMed Web of Science ®Google Scholar
• Daassi D, Mahoney KM, Freeman GJ. The importance of exosomal PDL1 in tumour immune evasion. Nat Rev Immunol. 2020;1–7.31792373
   PubMed Web of Science ®Google Scholar
• Fu W, Lei C, Liu S, et al. CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity. Nat Commun. 2019;10(1):1–12.30602773
   PubMedGoogle Scholar
• Morishita M, Takahashi Y, Nishikawa M, Takakura Y. Pharmacokinetics of exosomes—an important factor for elucidating the biological roles of exosomes and for the development of exosome-based therapeutics. J Pharm Sci. 2017;106(9):2265–2269. doi:10.1016/j.xphs.2017.02.03028283433
   PubMed Web of Science ®Google Scholar
• Ferguson S, Kim S, Lee C, Deci M, Nguyen J. The phenotypic effects of exosomes secreted from distinct cellular sources: a comparative study based on miRNA composition. AAPS J. 2018;20(4):67. doi:10.1208/s12248-018-0227-429713834
   PubMed Web of Science ®Google Scholar
• Chiu YJ, Cai W, Shih YRV, Lian I, Lo YH. A single‐cell assay for time lapse studies of exosome secretion and cell behaviors. Small. 2016;12(27):3658–3666. doi:10.1002/smll.20160072527254278
   PubMed Web of Science ®Google Scholar
• Charoenviriyakul C, Takahashi Y, Morishita M, Matsumoto A, Nishikawa M, Takakura Y. Cell type-specific and common characteristics of exosomes derived from mouse cell lines: yield, physicochemical properties, and pharmacokinetics. Eur J Pharm Sci. 2017;96:316–322. doi:10.1016/j.ejps.2016.10.00927720897
   PubMed Web of Science ®Google Scholar
• Wu J-Y, Ji A-L, Wang Z-X, et al. Exosome-Mimetic Nanovesicles from Hepatocytes promote hepatocyte proliferation in vitro and liver regeneration in vivo. Sci Rep. 2018;8(1):1–11.29311619
   PubMedGoogle Scholar
• Oh K, Kim SR, Kim D-K, et al. In vivo differentiation of therapeutic insulin-producing cells from bone marrow cells via extracellular vesicle-mimetic nanovesicles. ACS Nano. 2015;9(12):11718–11727. doi:10.1021/acsnano.5b0299726513554
   PubMed Web of Science ®Google Scholar
• Jang SC, Kim OY, Yoon CM, et al. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano. 2013;7(9):7698–7710. doi:10.1021/nn402232g24004438
   PubMed Web of Science ®Google Scholar
• Skotland T, Hessvik NP, Sandvig K, Llorente A. Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology. J Lipid Res. 2019;60(1):9–18.30076207
   PubMed Web of Science ®Google Scholar
• Liu X, Sun Y, Xu S, et al. Homotypic cell membrane-cloaked biomimetic nanocarrier for the targeted chemotherapy of hepatocellular carcinoma. Theranostics. 2019;9(20):5828. doi:10.7150/thno.3483731534522
   PubMed Web of Science ®Google Scholar
• Lin Y, Wu J, Gu W, et al. Exosome–liposome hybrid nanoparticles deliver CRISPR/Cas9 system in MSCs. Advanced Science. 2018;5(4):1700611. doi:10.1002/advs.20170061129721412
   PubMed Web of Science ®Google Scholar
• Armstrong JP, Stevens MM. Strategic design of extracellular vesicle drug delivery systems. Adv Drug Deliv Rev. 2018;130:12–16. doi:10.1016/j.addr.2018.06.01729959959
   PubMed Web of Science ®Google Scholar
• Morishita M, Takahashi Y, Nishikawa M, et al. Quantitative analysis of tissue distribution of the B16BL6-derived exosomes using a streptavidin-lactadherin fusion protein and iodine-125-labeled biotin derivative after intravenous injection in mice. J Pharm Sci. 2015;104(2):705–713. doi:10.1002/jps.2425125393546
   PubMed Web of Science ®Google Scholar
• Wan Z, Zhao L, Lu F, et al. Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium. Theranostics. 2020;10(1):218. doi:10.7150/thno.3819831903116
   PubMed Web of Science ®Google Scholar
• Elsharkasy OM, Nordin JZ, Hagey DW, et al. Extracellular vesicles as drug delivery systems: why and how? Adv Drug Deliv Rev. 2020. doi:10.1016/j.addr.2020.04.004
   PubMedGoogle Scholar
• Matsumoto A, Takahashi Y, Nishikawa M, et al. Role of phosphatidylserine-derived negative surface charges in the recognition and uptake of intravenously injected B16BL6-derived exosomes by macrophages. J Pharm Sci. 2017;106(1):168–175. doi:10.1016/j.xphs.2016.07.02227649887
   PubMed Web of Science ®Google Scholar
• Clayton A, Harris CL, Court J, Mason MD, Morgan BP. Antigen‐presenting cell exosomes are protected from complement‐mediated lysis by expression of CD55 and CD59. Eur J Immunol. 2003;33(2):522–531. doi:10.1002/immu.20031002812645951
   PubMed Web of Science ®Google Scholar
• Wang Q-L, Zhuang X, Sriwastva MK, et al. Blood exosomes regulate the tissue distribution of grapefruit-derived nanovector via CD36 and IGFR1 pathways. Theranostics. 2018;8(18):4912. doi:10.7150/thno.2760830429877
   PubMed Web of Science ®Google Scholar
• Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33(9):941. doi:10.1038/nbt.333026348965
   PubMed Web of Science ®Google Scholar
• Hoshino A, Costa-Silva B, Shen T-L, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527(7578):329–335. doi:10.1038/nature1575626524530
   PubMed Web of Science ®Google Scholar
• Berenguer J, Lagerweij T, Zhao XW, et al. Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8. J Extracellular Vesicles. 2018;7(1):1446660. doi:10.1080/20013078.2018.144666029696074
   PubMed Web of Science ®Google Scholar
• Parolini I, Federici C, Raggi C, et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem. 2009;284(49):34211–34222. doi:10.1074/jbc.M109.04115219801663
   PubMed Web of Science ®Google Scholar
• Saari H, Lázaro-Ibáñez E, Viitala T, Vuorimaa-Laukkanen E, Siljander P, Yliperttula M. Microvesicle-and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. J Control Release. 2015;220:727–737. doi:10.1016/j.jconrel.2015.09.03126390807
   PubMed Web of Science ®Google Scholar
• Qiao L, Hu S, Huang K, et al. Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs. Theranostics. 2020;10(8):3474. doi:10.7150/thno.3943432206102
   PubMed Web of Science ®Google Scholar
• Watson DC, Bayik D, Srivatsan A, et al. Efficient production and enhanced tumor delivery of engineered extracellular vesicles. Biomaterials. 2016;105:195–205. doi:10.1016/j.biomaterials.2016.07.00327522254
   PubMed Web of Science ®Google Scholar
• Rosenblum D, Joshi N, Tao W, Karp JM, Peer D. Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun. 2018;9(1):1–12. doi:10.1038/s41467-018-03705-y29317637
   PubMedGoogle Scholar
• Chauhan VP, Jain RK. Strategies for advancing cancer nanomedicine. Nat Mater. 2013;12(11):958. doi:10.1038/nmat379224150413
   PubMed Web of Science ®Google Scholar
• Kirpotin DB, Drummond DC, Shao Y, et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res. 2006;66(13):6732–6740. doi:10.1158/0008-5472.CAN-05-419916818648
   PubMed Web of Science ®Google Scholar
• Ojha T, Pathak V, Shi Y, et al. Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors. Adv Drug Deliv Rev. 2017;119:44–60. doi:10.1016/j.addr.2017.07.00728697952
   PubMed Web of Science ®Google Scholar
• Yang Z, Shi J, Xie J, et al. Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation. Nature Biomedical Engineering. 2020;4(1):69–83. doi:10.1038/s41551-019-0485-1
   PubMed Web of Science ®Google Scholar
• Shi S, Li T, Wen X, et al. Copper-64 labeled PEGylated exosomes for in vivo positron emission tomography and enhanced tumor retention. Bioconjug Chem. 2019;30(10):2675–2683. doi:10.1021/acs.bioconjchem.9b0058731560538
   PubMed Web of Science ®Google Scholar
• Shi S, Wen X, Li T, Xiong C, Sood A. Radiolabeled pegylated exosomes for in vivo pet imaging and enhanced tumor retention. J Nucl Med. 2019;60(supplement 1):349.
   Google Scholar
• d’Avanzo N, Celia C, Barone A, et al. Immunogenicity of polyethylene glycol based nanomedicines: mechanisms, clinical implications and systematic approach. Advanced Therapeutics. 2020;3(3):1900170. doi:10.1002/adtp.201900170
   Google Scholar
• Kooijmans S, Fliervoet L, Van Der Meel R, et al. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. J Control Release. 2016;224:77–85. doi:10.1016/j.jconrel.2016.01.00926773767
   PubMed Web of Science ®Google Scholar
• Sugahara KN, Teesalu T, Karmali PP, et al. Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell. 2009;16(6):510–520. doi:10.1016/j.ccr.2009.10.01319962669
   PubMed Web of Science ®Google Scholar
• Yong T, Wang D, Li X, et al. Extracellular vesicles for tumor targeting delivery based on five features principle. J Control Release. 2020;322:555–565. doi:10.1016/j.jconrel.2020.03.03932246977
   PubMed Web of Science ®Google Scholar
• Zhou Q, Dong C, Fan W, et al. Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: the current status and transcytosis strategy. Biomaterials. 2020;240:119902. doi:10.1016/j.biomaterials.2020.11990232105817
   PubMed Web of Science ®Google Scholar
• Sharpe AH, Pauken KE. The diverse functions of the PD1 inhibitory pathway. Nat Rev Immunol. 2018;18(3):153. doi:10.1038/nri.2017.10828990585
   PubMed Web of Science ®Google Scholar
• Cheng Q, Shi X, Han M, Smbatyan G. Reprogramming exosomes as nanoscale controllers of cellular immunity. J Am Chem Soc. 2018;140(48):16413–16417. doi:10.1021/jacs.8b1004730452238
   PubMed Web of Science ®Google Scholar
• Topp MS, Gökbuget N, Stein AS, et al. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, Phase 2 study. Lancet Oncol. 2015;16(1):57–66. doi:10.1016/S1470-2045(14)71170-225524800
   PubMed Web of Science ®Google Scholar
• Dusoswa SA, Horrevorts SK, Ambrosini M, et al. Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells. J Extracellular Vesicles. 2019;8(1):1648995. doi:10.1080/20013078.2019.164899531489145
   PubMed Web of Science ®Google Scholar
• Qian Y, Qiao S, Dai Y, et al. Molecular-targeted immunotherapeutic strategy for melanoma via dual-targeting nanoparticles delivering small interfering RNA to tumor-associated macrophages. ACS Nano. 2017;11(9):9536–9549. doi:10.1021/acsnano.7b0546528858473
   PubMed Web of Science ®Google Scholar
• Penn CA, Yang K, Zong H, et al. Therapeutic impact of nanoparticle therapy targeting tumor-associated macrophages. Mol Cancer Ther. 2018;17(1):96–106. doi:10.1158/1535-7163.MCT-17-068829133618
   PubMed Web of Science ®Google Scholar
• Liu R, Li X, Zhu W, et al. Cholangiocyte‐derived exosomal long noncoding RNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis. Hepatology. 2019;70(4):1317–1335. doi:10.1002/hep.3066230985008
   PubMed Web of Science ®Google Scholar
• Costa-Silva B, Aiello NM, Ocean AJ, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17(6):816–826. doi:10.1038/ncb316925985394
   PubMed Web of Science ®Google Scholar
• Saunderson SC, Dunn AC, Crocker PR, McLellan AD. CD169 mediates the capture of exosomes in spleen and lymph node. Blood J American Society Hematology. 2014;123(2):208–216.
   Google Scholar
• Tamura R, Uemoto S, Tabata Y. Augmented liver targeting of exosomes by surface modification with cationized pullulan. Acta Biomater. 2017;57:274–284. doi:10.1016/j.actbio.2017.05.01328483695
   PubMed Web of Science ®Google Scholar
• Ohno S-I, Takanashi M, Sudo K, et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther. 2013;21(1):185–191. doi:10.1038/mt.2012.18023032975
   PubMed Web of Science ®Google Scholar
• Won Y-W, McGinn AN, Lee M, Bull DA, Kim SW. Targeted gene delivery to ischemic myocardium by homing peptide-guided polymeric carrier. Mol Pharm. 2013;10(1):378–385. doi:10.1021/mp300500y23214982
   PubMedGoogle Scholar
• Longatti A, Schindler C, Collinson A, et al. High affinity single-chain variable fragments are specific and versatile targeting motifs for extracellular vesicles. Nanoscale. 2018;10(29):14230–14244.30010165
   PubMed Web of Science ®Google Scholar
• Hung ME, Leonard JN. Stabilization of exosome-targeting peptides via engineered glycosylation. J Biol Chem. 2015;290(13):8166–8172. doi:10.1074/jbc.M114.62138325657008
   PubMed Web of Science ®Google Scholar
• Véron P, Segura E, Sugano G, Amigorena S, Théry C. Accumulation of MFG-E8/lactadherin on exosomes from immature dendritic cells. Blood Cells Mol Dis. 2005;35(2):81–88. doi:10.1016/j.bcmd.2005.05.00115982908
   PubMed Web of Science ®Google Scholar
• Kooijmans SA, Aleza CG, Roffler SR, van Solinge WW, Vader P, Schiffelers RM. Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting. J Extracellular Vesicles. 2016;5(1):31053. doi:10.3402/jev.v5.3105326979463
   PubMedGoogle Scholar
• Jackson HJ, Rafiq S, Brentjens RJ. Driving CAR T-cells forward. Nat Rev Clin Oncol. 2016;13(6):370–383. doi:10.1038/nrclinonc.2016.3627000958
   PubMed Web of Science ®Google Scholar
• Thevendran R, Sarah S, Tang T-H, Citartan M. Strategies to bioengineer aptamer-driven nanovehicles as exceptional molecular tools for targeted therapeutics: A review. J Control Release. 2020.
   PubMed Web of Science ®Google Scholar
• Han Z, Lv W, Li Y, et al. Improving tumor targeting of exosomal membrane-coated polymeric nanoparticles by conjugation with aptamers. ACS Applied Bio Materials. 2020;3(5):2666–2673. doi:10.1021/acsabm.0c00181
   PubMedGoogle Scholar
• Gulei D, Berindan-Neagoe I. Activation of necroptosis by engineered self tumor-derived exosomes loaded with CRISPR/Cas9. Molecular Therapy-Nucleic Acids. 2019;17:448–451.31323464
   PubMed Web of Science ®Google Scholar
• Liu Y, Bai L, Guo K, et al. Focused ultrasound-augmented targeting delivery of nanosonosensitizers from homogenous exosomes for enhanced sonodynamic cancer therapy. Theranostics. 2019;9(18):5261. doi:10.7150/thno.3318331410214
   PubMed Web of Science ®Google Scholar
• Cao Y, Wu T, Zhang K, et al. Engineered exosome-mediated near-infrared-II region V2C quantum dot delivery for nucleus-target low-temperature photothermal therapy. ACS Nano. 2019;13(2):1499–1510.30677286
   PubMed Web of Science ®Google Scholar
• Qi H, Liu C, Long L, et al. Blood exosomes endowed with magnetic and targeting properties for cancer therapy. ACS Nano. 2016;10(3):3323–3333. doi:10.1021/acsnano.5b0693926938862
   PubMed Web of Science ®Google Scholar
• Nakase I, Noguchi K, Fujii I, Futaki S. Vectorization of biomacromolecules into cells using extracellular vesicles with enhanced internalization induced by macropinocytosis. Sci Rep. 2016;6:34937. doi:10.1038/srep3493727748399
   PubMed Web of Science ®Google Scholar
• Yang Y, Hong Y, Nam GH, Chung JH, Koh E, Kim IS. Virus‐mimetic fusogenic exosomes for direct delivery of integral membrane proteins to target cell membranes. Adv Mater. 2017;29(13):1605604. doi:10.1002/adma.201605604
   Web of Science ®Google Scholar
• Lu M, Zhao X, Xing H, et al. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery. Acta Biomater. 2019;96:517–536.31284098
   PubMed Web of Science ®Google Scholar
• Nakase I, Futaki S. Combined treatment with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes. Sci Rep. 2015;5:10112. doi:10.1038/srep1011226011176
   PubMed Web of Science ®Google Scholar
• Svensson KJ, Christianson HC, Wittrup A, et al. Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1. J Biol Chem. 2013;288(24):17713–17724. doi:10.1074/jbc.M112.44540323653359
   PubMed Web of Science ®Google Scholar
• Horibe S, Tanahashi T, Kawauchi S, Murakami Y, Rikitake Y. Mechanism of recipient cell-dependent differences in exosome uptake. BMC Cancer. 2018;18(1):47. doi:10.1186/s12885-017-3958-129306323
   PubMed Web of Science ®Google Scholar
• Santos MF, Rappa G, Karbanová J, Kurth T, Corbeil D, Lorico A. VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum. J Biol Chem. 2018;293(36):13834–13848. doi:10.1074/jbc.RA118.00372530018135
   PubMed Web of Science ®Google Scholar
• Yang T, Martin P, Fogarty B, et al. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio. Pharm Res. 2015;32(6):2003–2014. doi:10.1007/s11095-014-1593-y25609010
   PubMed Web of Science ®Google Scholar
• Yuan D, Zhao Y, Banks WA, et al. Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain. Biomaterials. 2017;142:1–12. doi:10.1016/j.biomaterials.2017.07.01128715655
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29(4):341–345. doi:10.1038/nbt.180721423189
   PubMed Web of Science ®Google Scholar
• Betker JL, Angle BM, Graner MW, Anchordoquy TJ. The potential of exosomes from cow milk for oral delivery. J Pharm Sci. 2019;108(4):1496–1505. doi:10.1016/j.xphs.2018.11.02230468828
   PubMed Web of Science ®Google Scholar
• Zhang M, Viennois E, Xu C, Merlin D. Plant derived edible nanoparticles as a new therapeutic approach against diseases. Tissue Barriers. 2016;4(2):e1134415. doi:10.1080/21688370.2015.113441527358751
   PubMed Web of Science ®Google Scholar
• Manca S, Upadhyaya B, Mutai E, et al. Milk exosomes are bioavailable and distinct microRNA cargos have unique tissue distribution patterns. Sci Rep. 2018;8(1):11321. doi:10.1038/s41598-018-29780-130054561
   PubMedGoogle Scholar
• Batrakova EV, Kim MS. Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release. 2015;219:396–405. doi:10.1016/j.jconrel.2015.07.03026241750
   PubMed Web of Science ®Google Scholar
• Wang Y, Yu D, Liu Z, et al. Exosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix. Stem Cell Res Ther. 2017;8(1):189. doi:10.1186/s13287-017-0632-028807034
   PubMedGoogle Scholar
• Li SP, Lin ZX, Jiang XY, Yu XY. Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools. Acta Pharmacol Sin. 2018;39(4):542–551. doi:10.1038/aps.2017.17829417947
   PubMed Web of Science ®Google Scholar
• Fais S, O’Driscoll L, Borras FE, et al. Evidence-based clinical use of nanoscale extracellular vesicles in nanomedicine. ACS Nano. 2016;10:3886–3899. doi:10.1021/acsnano.5b0801526978483
   PubMed Web of Science ®Google Scholar
• Lamparski HG, Metha-Damani A, Yao J-Y, et al. Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods. 2002;270(2):211–226. doi:10.1016/S0022-1759(02)00330-712379326
   PubMed Web of Science ®Google Scholar
• Pang XL, Wang ZG, Liu L, et al. Immature dendritic cells derived exosomes promotes immune tolerance by regulating T cell differentiation in renal transplantation. Aging. 2019;11(20):8911–8924.31655796
   PubMedGoogle Scholar
• Wang G, Hu W, Chen H, Shou X, Ye T, Xu Y. Cocktail strategy based on nk cell-derived exosomes and their biomimetic nanoparticles for dual tumor therapy. Cancers. 2019;11(10):1560. doi:10.3390/cancers11101560
   PubMed Web of Science ®Google Scholar
• Hoang DH, Nguyen TD, Nguyen H-P, et al. Differential wound healing capacity of mesenchymal stem cell-derived exosomes originated from bone marrow, adipose tissue and umbilical cord under serum-and xeno-free condition. Frontiers Molecular Biosciences. 2020;7.
   PubMed Web of Science ®Google Scholar
• Chen H-X, Liang F-C, Gu P, et al. Exosomes derived from mesenchymal stem cells repair a Parkinson’s disease model by inducing autophagy. Cell Death Dis. 2020;11(4):1–17.31911576
   PubMed Web of Science ®Google Scholar
• Sawada S-I, Sato YT, Kawasaki R, et al. Nanogel hybrid assembly for exosome intracellular delivery: effects on endocytosis and fusion by exosome surface polymer engineering. Biomaterials Science. 2020;8(2):619–630. doi:10.1039/C9BM01232J31833484
   PubMed Web of Science ®Google Scholar
• Kalimuthu S, Gangadaran P, Rajendran RL, et al. A new approach for loading anticancer drugs into mesenchymal stem cell-derived exosome mimetics for cancer therapy. Front Pharmacol. 2018;9:1116.30319428
   PubMed Web of Science ®Google Scholar
• Iravani S, Varma RS. Plant-derived edible nanoparticles and miRNAs: emerging frontier for therapeutics and targeted drug-delivery. ACS Sustain Chem Eng. 2019;7(9):8055–8069. doi:10.1021/acssuschemeng.9b00954
   Web of Science ®Google Scholar
• Si Y, Kim S, Zhang E, et al. Targeted exosomes for drug delivery: biomanufacturing, surface tagging, and validation. Biotechnol J. 2020;15(1):e1900163. doi:10.1002/biot.20190016331595685
   PubMed Web of Science ®Google Scholar
• Nie H, Xie X, Zhang D, et al. Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer. Nanoscale. 2020;12(2):877–887. doi:10.1039/C9NR09011H31833519
   PubMed Web of Science ®Google Scholar
• Wang J, Li W, Zhang L, et al. Chemically edited exosomes with dual ligand purified by microfluidic device for active targeted drug delivery to tumor cells. ACS Appl Mater Interfaces. 2017;9(33):27441–27452. doi:10.1021/acsami.7b0646428762264
   PubMed Web of Science ®Google Scholar
• Nakase I, Ueno N, Katayama M, et al. Receptor clustering and activation by multivalent interaction through recognition peptides presented on exosomes. Chem Commun. 2016;53(2):317–320. doi:10.1039/C6CC06719K
   PubMed Web of Science ®Google Scholar
• Zou J, Shi M, Liu X, et al. Aptamer-functionalized exosomes: elucidating the cellular uptake mechanism and the potential for cancer-targeted chemotherapy. Anal Chem. 2019;91(3):2425–2430. doi:10.1021/acs.analchem.8b0520430620179
   PubMed Web of Science ®Google Scholar
• Munagala R, Aqil F, Jeyabalan J, Gupta RC. Bovine milk-derived exosomes for drug delivery. Cancer Lett. 2016;371(1):48–61. doi:10.1016/j.canlet.2015.10.02026604130
   PubMed Web of Science ®Google Scholar
• Shimoda A, Tahara Y, Sawada SI, Sasaki Y, Akiyoshi K. Glycan profiling analysis using evanescent-field fluorescence-assisted lectin array: importance of sugar recognition for cellular uptake of exosomes from mesenchymal stem cells. Biochem Biophys Res Commun. 2017;491(3):701–707. doi:10.1016/j.bbrc.2017.07.12628751214
   PubMed Web of Science ®Google Scholar
• Zhuang X, Xiang X, Grizzle W, et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther. 2011;19(10):1769–1779. doi:10.1038/mt.2011.16421915101
   PubMed Web of Science ®Google Scholar
• Haney MJ, Klyachko NL, Zhao Y, et al. Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release. 2015;207:18–30. doi:10.1016/j.jconrel.2015.03.03325836593
   PubMed Web of Science ®Google Scholar
• Liu Y, Li D, Liu Z, et al. Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse. Sci Rep. 2015;5:17543. doi:10.1038/srep1754326633001
   PubMed Web of Science ®Google Scholar
• Tian T, Zhang HX, He CP, et al. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials. 2018;150:137–149. doi:10.1016/j.biomaterials.2017.10.01229040874
   PubMed Web of Science ®Google Scholar
• Jia G, Han Y, An Y, et al. NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. Biomaterials. 2018;178:302–316. doi:10.1016/j.biomaterials.2018.06.02929982104
   PubMed Web of Science ®Google Scholar